ERBB2 and ovarian carcinoma: In ovarian cancer, there are multiple tumour-associated antigen molecules detected on the surface or inside the cell, which can likely serve as targets for immune recognition and response—e.g., CA125, p53 protein, FRα, HER2, and cancer-testis antigens, such as MAGE-A4 and NY-ESO-1 [92].